Site Members can sign up for company wide alerts
An investigation on behalf of current long term investors in Novo Nordisk A/S (ADR) (NYSE:NVO) in connection with possible violations of the U.S. Foreign Corrupt Practices Act was announced. Novo Nordisk A/S is a Denmark-based health care company. It also focuses within areas, such as haemostasis management, growth hormone therapy and hormone replacement therapy. According to the inve...
You must register (for free) or login to view the entire investigation.